Telomir Total Other Income Expense Net vs Operating Income Analysis

TELO Stock   5.18  0.64  14.10%   
Telomir Pharmaceuticals, financial indicator trend analysis is much more than just breaking down Telomir Pharmaceuticals, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Telomir Pharmaceuticals, is a good investment. Please check the relationship between Telomir Pharmaceuticals, Total Other Income Expense Net and its Operating Income accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Total Other Income Expense Net vs Operating Income

JavaScript chart by amCharts 3.21.15201420162018202020222024-9M-8.5M-8M-7.5M-7M-6.5M-6M-5.5M-5M-4.5M-4M-3.5M-3M-2.5M-2M-1.5M-1M-500K0 -4M-3.5M-3M-2.5M-2M-1.5M-1M-500K
JavaScript chart by amCharts 3.21.15Total Other Income Expense Nettotal: -25.2MOperating Incometotal: -12.8M

Total Other Income Expense Net vs Operating Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Telomir Pharmaceuticals, Total Other Income Expense Net account and Operating Income. At this time, the significance of the direction appears to have totally related.
Total Other Income Expense NetOperating IncomeDiversified AwayTotal Other Income Expense NetOperating IncomeDiversified Away100%
The correlation between Telomir Pharmaceuticals,'s Total Other Income Expense Net and Operating Income is 0.99. Overlapping area represents the amount of variation of Total Other Income Expense Net that can explain the historical movement of Operating Income in the same time period over historical financial statements of Telomir Pharmaceuticals, Common, assuming nothing else is changed. The correlation between historical values of Telomir Pharmaceuticals,'s Total Other Income Expense Net and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Other Income Expense Net of Telomir Pharmaceuticals, Common are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Total Other Income Expense Net i.e., Telomir Pharmaceuticals,'s Total Other Income Expense Net and Operating Income go up and down completely randomly.

Correlation Coefficient

0.99
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Other Income Expense Net

Operating Income

Operating Income is the amount of profit realized from Telomir Pharmaceuticals, operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Telomir Pharmaceuticals, Common is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.
Most indicators from Telomir Pharmaceuticals,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Telomir Pharmaceuticals, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At this time, Telomir Pharmaceuticals,'s Selling General Administrative is very stable compared to the past year. As of the 22nd of December 2024, Issuance Of Capital Stock is likely to grow to about 1.2 M, while Enterprise Value Over EBITDA is likely to drop (19.05).

Telomir Pharmaceuticals, fundamental ratios Correlations

-0.130.23-0.34-0.391.00.180.150.18-0.220.23-0.34-0.411.0-0.22-0.180.22-0.210.180.180.18
-0.130.890.98-0.85-0.13-0.980.9-0.81.00.890.98-0.84-0.131.00.79-0.980.93-0.8-0.8-0.8
0.230.890.8-0.950.23-0.891.0-0.530.851.00.8-0.950.230.850.69-0.80.9-0.53-0.53-0.53
-0.340.980.8-0.73-0.34-0.970.83-0.780.990.81.0-0.71-0.340.990.78-0.970.93-0.78-0.78-0.78
-0.39-0.85-0.95-0.73-0.390.83-0.930.58-0.8-0.95-0.731.0-0.39-0.8-0.570.77-0.770.580.580.58
1.0-0.130.23-0.34-0.390.180.150.18-0.230.23-0.34-0.411.0-0.23-0.180.22-0.210.180.180.18
0.18-0.98-0.89-0.970.830.18-0.910.69-0.99-0.89-0.980.820.18-0.99-0.710.94-0.960.690.690.69
0.150.91.00.83-0.930.15-0.91-0.520.871.00.83-0.920.150.870.7-0.820.93-0.52-0.52-0.52
0.18-0.8-0.53-0.780.580.180.69-0.52-0.79-0.53-0.780.570.18-0.79-0.80.89-0.571.01.01.0
-0.221.00.850.99-0.8-0.23-0.990.87-0.790.850.99-0.79-0.221.00.79-0.980.94-0.79-0.79-0.79
0.230.891.00.8-0.950.23-0.891.0-0.530.850.8-0.950.230.850.69-0.80.9-0.53-0.53-0.53
-0.340.980.81.0-0.73-0.34-0.980.83-0.780.990.8-0.71-0.340.990.78-0.970.93-0.78-0.78-0.78
-0.41-0.84-0.95-0.711.0-0.410.82-0.920.57-0.79-0.95-0.71-0.41-0.79-0.560.75-0.760.570.570.57
1.0-0.130.23-0.34-0.391.00.180.150.18-0.220.23-0.34-0.41-0.22-0.180.22-0.210.180.180.18
-0.221.00.850.99-0.8-0.23-0.990.87-0.791.00.850.99-0.79-0.220.79-0.980.94-0.79-0.79-0.79
-0.180.790.690.78-0.57-0.18-0.710.7-0.80.790.690.78-0.56-0.180.79-0.850.76-0.8-0.8-0.8
0.22-0.98-0.8-0.970.770.220.94-0.820.89-0.98-0.8-0.970.750.22-0.98-0.85-0.880.890.890.89
-0.210.930.90.93-0.77-0.21-0.960.93-0.570.940.90.93-0.76-0.210.940.76-0.88-0.57-0.57-0.57
0.18-0.8-0.53-0.780.580.180.69-0.521.0-0.79-0.53-0.780.570.18-0.79-0.80.89-0.571.01.0
0.18-0.8-0.53-0.780.580.180.69-0.521.0-0.79-0.53-0.780.570.18-0.79-0.80.89-0.571.01.0
0.18-0.8-0.53-0.780.580.180.69-0.521.0-0.79-0.53-0.780.570.18-0.79-0.80.89-0.571.01.0
Click cells to compare fundamentals

Telomir Pharmaceuticals, Account Relationship Matchups

Pair Trading with Telomir Pharmaceuticals,

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Telomir Pharmaceuticals, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will appreciate offsetting losses from the drop in the long position's value.

Moving together with Telomir Stock

  0.63A Agilent TechnologiesPairCorr
  0.61ME 23Andme HoldingPairCorr

Moving against Telomir Stock

  0.69DRUG Bright Minds BiosciencesPairCorr
  0.5SABSW SAB BiotherapeuticsPairCorr
  0.47VANI Vivani MedicalPairCorr
  0.38VNDA Vanda PharmaceuticalsPairCorr
  0.32KTTAW Pasithea TherapeuticsPairCorr
The ability to find closely correlated positions to Telomir Pharmaceuticals, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Telomir Pharmaceuticals, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Telomir Pharmaceuticals, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Telomir Pharmaceuticals, Common to buy it.
The correlation of Telomir Pharmaceuticals, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Telomir Pharmaceuticals, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Telomir Pharmaceuticals, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Telomir Pharmaceuticals, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Telomir Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Telomir Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Telomir Pharmaceuticals, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Telomir Pharmaceuticals, Common Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telomir Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Telomir Pharmaceuticals,. If investors know Telomir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Telomir Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.77)
Return On Assets
(2.05)
Return On Equity
(17.53)
The market value of Telomir Pharmaceuticals, is measured differently than its book value, which is the value of Telomir that is recorded on the company's balance sheet. Investors also form their own opinion of Telomir Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is Telomir Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Telomir Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect Telomir Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Telomir Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Telomir Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Telomir Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.